Cargando…
Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature
BACKGROUND: Immune checkpoint inhibitors are a new promising class of antitumor drugs that have been associated with a number of immune-related Adverse Events (AEs), including musculoskeletal and rheumatic disease. METHODS: We searched Medline reviewing reports of musculoskeletal and rheumatic AEs i...
Autores principales: | Benfaremo, Devis, Manfredi, Lucia, Luchetti, Michele Maria, Gabrielli, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198478/ https://www.ncbi.nlm.nih.gov/pubmed/29745339 http://dx.doi.org/10.2174/1574886313666180508122332 |
Ejemplares similares
-
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs
por: Benfaremo, Devis, et al.
Publicado: (2019) -
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy
por: Benfaremo, Devis, et al.
Publicado: (2021) -
Isolated Aortitis Presenting with an Annoying Persistent Cough: A Case Report
por: Luchetti, Michele Maria, et al.
Publicado: (2016) -
Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?
por: Benfaremo, Devis, et al.
Publicado: (2019) -
Diagnosis and management of leukocytoclastic vasculitis
por: Fraticelli, Paolo, et al.
Publicado: (2021)